Tandem Diabetes Shares Surge on Analyst's Optimistic View

Tandem Diabetes shares surge by 4.5% following Morgan Stanleys price target increase, reflecting a more optimistic view on the companys future value, despite maintaining a neutral rating. The stocks volatility is well-known, with this recent movement falling within its typical range of fluctuations.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.